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Abstract 
Diffusion MRI is the modality of choice to study alterations of white matter. In the past years, 
various works have used diffusion MRI for automatic classification of Alzheimer’s disease. 
However, the performances obtained with different approaches are difficult to compare 
because of variations in components such as input data, participant selection, image 
preprocessing, feature extraction, feature selection (FS) and cross-validation (CV) procedure. 
Moreover, these studies are also difficult to reproduce because these different components are 
not readily available. In a previous work (Samper-González et al. 2018), we proposed an open-
source framework for the reproducible evaluation of AD classification from T1-weighted 
(T1w) MRI and PET data. In the present paper, we extend this framework to diffusion MRI 
data. The framework comprises: tools to automatically convert ADNI data into the BIDS 
standard, pipelines for image preprocessing and feature extraction, baseline classifiers and a 
rigorous CV procedure. We demonstrate the use of the framework through assessing the 
influence of diffusion tensor imaging (DTI) metrics (fractional anisotropy - FA, mean 
diffusivity - MD), feature types, imaging modalities (diffusion MRI or T1w MRI), data 
imbalance and FS bias. First, voxel-wise features generally gave better performances than 
regional features. Secondly, FA and MD provided comparable results for voxel-wise features. 
Thirdly, T1w MRI performed better than diffusion MRI. Fourthly, we demonstrated that using 
non-nested validation of FS leads to unreliable and over-optimistic results. All the code is 
publicly available: general-purpose tools have been integrated into the Clinica software 
(www.clinica.run) and the paper-specific code is available at: https://gitlab.icm-
institute.org/aramislab/AD-ML. 
Keywords: classification, machine learning, reproducibility, Alzheimer's disease, diffusion 
magnetic resonance imaging, DTI, open-source  
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1. Introduction 
Alzheimer's disease (AD), the most prevalent form of dementia, is expected to affect 1 out of 
85 people in the world by the year 2050 (Brookmeyer et al. 2007). Neuroimaging offers the 
possibility to study pathological brain changes associated with AD in vivo (Ewers et al. 2011). 
The most common neuroimaging modalities used to study AD are T1-weighted (T1w) 
magnetic resonance imaging (MRI) and positron emission tomography (PET) with various 
tracers (Frisoni et al. 2010; Vemuri & Jack 2010). These techniques allow studying different 
types of alterations in the gray matter (GM). However, while AD is often considered primarily 
a gray matter disease, white matter (WM) is also extensively altered. There has thus been an 
increased interest in using diffusion MRI to study alterations in WM as the disease progresses 
(Fellgiebel et al. 2006; Kantarci et al. 2001; Müller et al. 2005; Müller et al. 2007).  
In the past decades, there has been a strong interest in developing machine learning 
methods to assist diagnosis and prognosis of AD based on neuroimaging data (Rathore et al. 
2017a; Falahati et al. 2014; Haller et al. 2011). In particular, a large number of studies using 
machine learning have looked at the potential of diffusion MRI for AD classification 
(Maggipinto et al. 2017; Dyrba, Barkhof, et al. 2015; Lella et al. 2017; Cui et al. 2012; Xie et 
al. 2015; Li et al. 2014). Several of these studies make use of the same publicly available 
dataset: the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (adni.loni.usc.edu). 
However, classification performances are not directly comparable across these studies because 
of differences in participant selection, feature extraction and selection, and performance 
metrics. It is thus difficult to know which approach performs best and which components of 
the method have the greatest influence on classification performances. We recently proposed a 
framework for the reproducible evaluation of machine learning algorithms in AD and 
demonstrated its use on PET and T1w MRI data (Samper-González et al. 2018). The framework 
is composed of tools for management of public datasets and in particular their conversion into 
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the Brain Imaging Data Structure (BIDS) format (Gorgolewski et al., 2016), standardized 
preprocessing pipelines, feature extraction tools and classification algorithms as well as 
procedures for evaluation. This framework was devoted to T1w MRI and PET data. 
In the present work, we extend this framework to diffusion MRI data. We first perform 
a systematic review of the previous works devoted to automatic classification of AD using 
diffusion MRI data. We then present the different components of the framework, namely tools 
to convert ADNI diffusion MRI data into BIDS, preprocessing pipelines, feature extraction and 
selection methods and evaluation framework. We finally apply the framework to study the 
influence of various components on the classification performance: feature type (voxel-wise or 
regional features), imaging modality (T1w or diffusion MRI), data imbalance and feature 
selection (FS) strategy.  
All the code (both of the framework and of the experiments) is publicly available: the 
general-purpose tools have been incorporated into Clinica (Routier et al. 2018), an open-source 
software platform that we developed for brain image analysis, and the paper-specific code is 
available at: https://gitlab.icm-institute.org/aramislab/AD-ML.  
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2. State of the art  
AD is associated with altered integrity of WM, in particular the loss of cellular barriers that 
constrain free water motion (Xie et al. 2006). The fact that DTI was designed to study WM 
microstructure has led to the hypothesis that DTI-based features can be used for AD 
classification (Selnes et al. 2013). In recent years, a large body of research has been published 
for classification of AD using diffusion MRI. Here, we provide a review of these works.  
We performed an online search of publications concerning classification of AD using 
diffusion MRI. We included only publications in English language, only original research 
publications (excluding review papers) and only peer-reviewed papers (either in journals or in 
conference proceedings), thereby excluding abstracts and preprints. We first searched on 
PubMed with the following search criteria: i) keywords: “(((classification diffusion MRI 
alzheimer's disease[Title/Abstract]) OR classification DTI alzheimer's disease[Title/Abstract]) 
OR diagnosis DTI alzheimer's disease[Title/Abstract]) OR diagnosis diffusion MRI 
alzheimer's disease[Title/Abstract]”, ii) publication date: before the 31st October 2018, and iii) 
study species: humans. We identified 616 studies based on these criteria. Among these studies, 
105 review papers were excluded. Based on the abstract, we then selected only papers devoted 
to AD classification and using at least diffusion MRI. This resulted in 18 studies. Secondly, 
another query was performed on Scopus with the following criteria: i) keywords: “(TITLE-
ABS-KEY(classification OR diagnosis) AND TITLE-ABS-KEY((diffusion AND mri) OR dti) 
AND TITLE-ABS-KEY((alzheimer's OR alzheimer) AND disease))”, and ii) publication date 
before the search day (the 31st October 2018). This resulted in 425 studies. We then excluded 
104 review papers. Moreover, limiting to only peer-reviewed journals or conference 
proceedings resulted in 298 studies. Based on the abstract, we selected only papers devoted to 
AD classification and using at least diffusion MRI, resulting in 27 studies. After merging the 
studies found by both PubMed and Scopus, we obtained 32 studies. To complete this search, 
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we also did a search on Google Scholar with keywords: “classification diffusion MRI 
alzheimer's disease” or “classification DTI alzheimer's disease” or “diagnosis DTI alzheimer's 
disease” or “diagnosis diffusion MRI alzheimer's disease”. Two additional studies were 
included, resulting in a total of 34 studies which are presented in the current state-of-the-art 
section.  
These 34 studies can be categorized according to the following criteria. i) Studied 
modality. While the majority used only diffusion MRI, some used multimodal data (combining 
diffusion MRI with T1w MRI or functional MRI for instance). ii) Type of features. We 
subdivided between papers using DTI metric features, such as fractional anisotropy (FA) and 
mean diffusivity (MD), and those using more advanced features, such as tract-based or 
network-based features. iii) Classifiers. The most commonly used are support vector machines 
(SVM) but random forests (RF), logistic regression (LR), nearest neighbors (NN) or naive 
Bayes (NB) were also used in some studies. iv) Dataset. The most commonly used dataset is 
the ADNI although it does not constitute an overwhelming majority, unlike for T1w-MRI or 
PET studies. This is probably because diffusion MRI was not present in ADNI1. v) 
Classification tasks. Some studies focused on the discrimination between AD patients and CN 
(cognitively normal) subjects while other tackled classification of patients with MCI (mild 
cognitive impairment) or prediction of progression to AD among MCI patients. A summary of 
these characteristics for the different studies is presented in Tables 1 (for those using DTI 
metric features) and Table 2 (for connectivity or tractography features). Besides, if multimodal 
imaging or different type of features (i.e., DTI metric and more advanced features) were used 
in a study, we reported the accuracy of the best performance. 
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Table 1. Summary of the studies using DTI metric features for AD classification. 
Abbreviations: dMRI: diffusion MRI; T1w: T1-weighted MRI; fMRI: functional MRI. 
SVM: support vector machine; RVM: relevance vector machine; RF: random forest; NB: naive 
Bayes; LR: logistic regression; NN: nearest neighbor. 
1: accuracy; 2: area under the curve. 
EDSD: European DTI Study on Dementia; MAS: Sydney Memory and Aging; RRMC: 
Research and Resource Memory; HSA: Hospital de Santiago Apostol; PRODEM: Prospective 
Registry on Dementia study; ADNI: Alzheimer’s Disease Neuroimaging Initiative; IDC: Ilsan 
Dementia Cohort; MCXWH: Memory Clinical at Xuan Wu Hospital; TJH: Tong Ji Hospital; 
MICPNU: Memory Impairment Clinic of Pusan National University Hospital; UHG: 
University Hospital of Geneva; DZNE: German Center for Neurodegenerative Diseases 
Rostock database; Local: private database.  
RD: radial diffusivity; AD: axial diffusivity; MO: mode of anisotropy.  
a: non-amnestic Mild Cognitive Impairment; b: amnestic Mild Cognitive Impairment; c: MCI-
Aβ 42−; d: MCI-Aβ 42+; e: sd-aMCI, single domain amnestic MCI; f: sd-fMCI, single domain 
frontal MCI; g: md-aMCI, multiple domains amnestic MCI; h: late MCI; i: early MCI; --, not 
applicable. 
 
Study Subject Modality Feature Classifier Database Performance 
 
AD MCI CN     CN/ 
AD 
CN/ 
MCI 
sMCI/ 
pMCI 
AD/ 
MCI 
Ahmed et al. 
2017 
45 58 52 dMRI, T1w Hippocampal 
voxel MD 
SVM ADNI 0.901 0.791 -- 0.771 
Cui et al. 2012 -- 79b 204 dMRI, T1w Regional FA SVM MAS -- 0.711 -- -- 
Dyrba et al. 
2013 
137 -- 143 dMRI Voxel FA, MD SVM EDSD 0.831 -- -- -- 
Dyrba, 
Barkhof, et al. 
2015 
-- 35c, 
42d 
25 dMRI, T1w Voxel FA, MD, 
MO 
SVM EDSD -- 0.771,d 0.681 -- 
Dyrba, 
Grothe, et al. 
2015 
28 -- 25 dMRI, T1w, 
fMRI 
Regional FA, 
MD, MO 
SVM DZNE 0.892 -- -- -- 
Demirhan et 
al. 2015 
43 -- 70 dMRI Voxel and 
regional FA 
SVM ADNI 0.881 0.781 -- 0.861 
Friese et al. 
2010 
21 -- 20 dMRI, T1w Voxel FA, MD LR Local 0.882 -- -- -- 
Graña et al. 
2011 
20 -- 25 dMRI Voxel FA, MD SVM HSA 11 -- -- -- 
Gao et al. 
2015 
-- 41 63 dMRI, T1w, 
fMRI 
Regional FA -- UHG -- 0.851 -- -- 
Jung et al. 
2015 
27 18 -- dMRI, T1w Regional FA, 
MD 
SVM MICPNU -- -- -- 0.871 
Lee, Park, and 
Han 2015 
35 73 33 dMRI Voxel FA, MO SVM ADNI 0.881 -- -- 0.901 
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Lella et al. 
2017 
40 -- 40 dMRI Voxel FA, MD SVM, RF, 
NB 
ADNI 0.781 -- -- -- 
Mesrob et al. 
2012 
15 -- 16 dMRI, T1w Voxel and 
regional FA, 
MD 
SVM RRMC 11 -- -- -- 
M. Li et al. 
2014 
21 -- 15 dMRI, T1w Regional FA SVM TJH 0.941 -- -- -- 
Maggipinto et 
al. 2017 
90 90 89 dMRI Voxel FA, MD RF ADNI 0.761 0.601 -- -- 
O’Dwyer et 
al. 2012 
-- 19a,14b 40 dMRI Voxel FA, MD, 
RD, AD 
SVM EDSD -- 0.931 -- -- 
S. Haller et al. 
2013 
-- 18e, 13f, 
35g 
-- dMRI Voxel FA SVM Local -- -- 0.991,e,f -- 
Schouten et al. 
2016 
77 -- 173 dMRI, T1w, 
fMRI 
Regional FA, 
MD 
LR PRODEM 0.952 -- -- -- 
Termenon et 
al. 2011 
15 -- 20 dMRI Voxel FA, MD SVM, 
RVM, NN 
HSA 0.991 -- -- -- 
Y. Xie et al. 
2015 
-- 64b 64 dMRI, T1w Voxel FA, MD SVM MCXWH -- 0.841 -- -- 
Zhang and Liu 
2018 
48 39h, 75i 51 dMRI Regional FA, 
MD, RD, AD 
SVM, LR ADNI 0.901 -- 0.931 -- 
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Table 2. Summary of the studies using tract-based or network-based features for AD 
classification. 
Abbreviations: dMRI: diffusion MRI; T1w: T1-weighted MRI; fMRI: functional MRI. 
SVM: support vector machine; LDA: linear discriminant analysis; RF: random forest; NB: 
naive bayes; LR: logistic regression; NN: nearest neighbor. 
1: balanced accuracy; 2: accuracy; 3: area under the curve. 
DUBIAC: Duke-UNC Brain Imaging and Analysis Center; RRMC: Research and Resource 
Memory; PRODEM: Prospective Registry on Dementia study; ADNI: Alzheimer’s Disease 
Neuroimaging Initiative; NACC: National Alzheimer’s Coordinating Center; NorCog: 
Norwegian registry for persons being evaluated for cognitive symptoms in specialized health 
care. 
a: subjective decline MCI; b: late MCI; c: early MCI; --, not applicable. 
 
 
Study Subject Modality dMRI Feature Classifier Database Performance 
 
AD MCI CN     CN/ 
AD 
CN/ 
MCI 
sMCI/ 
pMCI 
AD/ 
MCI 
Amoroso et al. 
2017 
47 -- 52 dMRI Network measures -- ADNI 0.953 -- -- -- 
Cai et al. 2018 165 -- 165 dMRI, 
T1w 
Network measures LDA ADNI 0.852 -- -- -- 
Doan et al. 
2017 
79 55, 
30a 
-- dMRI Tract measures, regional 
FA, MD, RD, AD 
LR NorCog -- -- --  
0.713 
Ebadi et al. 
2017 
15 15 15 dMRI Network measures LR, RF, NB, 
SVM, NN 
-- 0.802 0.702 -- 0.802 
Lee, Park, and 
Han 2013 
-- 39 39 dMRI Tract measures, voxel 
and regional FA 
SVM ADNI -- 12 -- -- 
Lella et al. 2018 40 30 52 dMRI Network measures SVM ADNI 0.773 -- -- -- 
Nir et al. 2015 37 113 50 dMRI Tract measures, FA, MD SVM ADNI 0.852 0.792 -- -- 
Prasad et al. 
2015 
38 38b,74c 50 dMRI Network measures SVM ADNI 0.782 -- 0.632 -- 
Schouten et al. 
2017 
77 -- 173 dMRI Network measures, voxel 
FA, MD, RD, AD 
LR PRODEM 0.922 -- -- -- 
Wee et al. 2012 -- 10 17 dMRI, 
fMRI 
Network measures SVM DUBIAC -- 0.962 -- -- 
Wang et al. 
2018 
-- 169 379 dMRI, 
T1w 
Network measures SVM, RF ADNI, 
NACC 
-- 0.753 -- -- 
Zhu et al. 2014 -- 22 22 dMRI, 
fMRI 
Network measures SVM NACC -- 0.952 -- -- 
Zhan et al. 2015 39 112 51 dMRI Network measures LR ADNI 0.711 0.571  0.691 
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Twenty-one studies used DTI metrics as features (see details in Table 1). Among the 
DTI derived metrics, FA and MD were most frequently used (O’Dwyer et al. 2012; Maggipinto 
et al. 2017; Dyrba et al. 2013; Dyrba, Barkhof, et al. 2015; Lella et al. 2017; Mesrob et al. 2012; 
Zhang & Liu 2018; Termenon et al. 2011; Xie et al. 2015; Friese et al. 2010; Schouten et al. 
2016; Jung et al. 2015; Dyrba, Grothe, et al. 2015). Besides, radial diffusivity (RD), axial 
diffusivity (AD) and mode of anisotropy (MO) were also examined in some papers (O’Dwyer 
et al. 2012; Dyrba, Barkhof, et al. 2015; Lee et al. 2015; Zhang & Liu 2018; Dyrba, Grothe, et 
al. 2015). Voxel- and region-wise features were both used. For voxel-wise classification, all 
voxels from the segmented GM or WM were used. For region-wise classification, the mean 
value within each region of interest (ROI) of DTI metric maps were extracted using an 
anatomical atlas. The most commonly used atlases were the John Hopkins University (JHU) 
atlases (Hua et al. 2008). Ten studies adopted only diffusion MRI for AD classification 
(O’Dwyer et al. 2012; Maggipinto et al. 2017; Dyrba et al. 2013; Lella et al. 2017; Zhang & 
Liu 2018; Termenon et al. 2011; Demirhan et al. 2015; Haller et al. 2013; Graña et al. 2011; 
Lee et al. 2015). The other eleven studies looked at the potential of multimodal MRI, for 
instance T1w MRI and diffusion MRI, for AD diagnosis and compared the performances cross 
modalities. For the DTI metric-based studies, SVM was most frequently used (O’Dwyer et al. 
2012; Dyrba et al. 2013; Dyrba, Barkhof, et al. 2015; Lella et al. 2017; Cui et al. 2012; Mesrob 
et al. 2012; Zhang & Liu 2018; Termenon et al. 2011; Xie et al. 2015; Jung et al. 2015; 
Demirhan et al. 2015; Ahmed et al. 2017; Li et al. 2014; Lee et al. 2015; Graña et al. 2011; 
Haller et al. 2013; Dyrba, Grothe, et al. 2015).  
Thirteen works demonstrated the usage of more complex features, such as tract-based 
or network-based features (see details in Table 2). In such approaches, tractography is used to 
extract WM tracts from diffusion MRI data. To be reliable, such a procedure requires to have 
high angular resolution diffusion imaging data. Then, tract-based approaches compute indices 
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that characterize the tract, including tract volume, average FA/MD across the tract or more 
advanced features (Doan et al. 2017; Nir et al. 2015; Lee et al. 2013). Such indices are used as 
input of the classifier. In network-based features, the result of the tractography (also called the 
tractogram) is used to build a graph of anatomical connections. Usually, the GM is parcellated 
into a set of anatomical regions and the connectivity between two given regions is computed 
based on the tractogram. To that purpose, different measures have been used, including the 
number of fibers or the average FA along the connection. This results in a connectivity network 
which can be described through network-based measures. Such features characterize the local 
and global topology of the network and are fed to a classifier. Ten studies used network-based 
features derived from diffusion MRI for AD classification (Schouten et al. 2017; Ebadi et al. 
2017; Prasad et al. 2015; Wee et al. 2012; Cai et al. 2018; Lella et al. 2018; Wang et al. 2018; 
Zhan et al. 2015; Amoroso et al. 2017; Zhu et al. 2014).  
There is a high variability in terms of classification performances across studies. For 
DTI metric features, the classification accuracy ranges from 0.71 to 1 for task CN vs AD. With 
regard to the accuracies across types of features, no consistency existed across studies. For 
instance, Nir et al observed that, in their study, the performances of MD outperformed FA (Nir 
et al. 2015). However, O’Dwyer et al reported higher accuracy for FA than MD in their 
experiments (O’Dwyer et al. 2012) and another study obtained comparable accuracies for both 
metrics (Dyrba et al. 2013). Conflicting results were also reported for the comparison of 
different modalities. Mesrob et al obtained higher accuracy with T1w MRI than with diffusion 
MRI (Mesrob et al. 2012) while Dyrba et al came to the opposite conclusion (Dyrba, Barkhof, 
et al. 2015). For network- or tract-based features, the classification accuracy ranges from 0.71 
to 0.95 for task CN vs AD, a range which is comparable to that obtained with DTI metrics.  
In this work, we choose to focus on DTI metrics because: i) they are more simple than 
connectivity or tractography features; ii) they can be easily computed and can make use of 
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standard diffusion MRI sequences, thus are more adapted to translation to clinical practice, iii) 
to date, there is no clear evidence that connectivity/tractography features lead to higher 
accuracies for AD classification and iv) conflicting results exist regarding the respective 
performance of different DTI metrics in this context.  
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 3. Materials 
The data used in the preparation of this article were obtained from the Alzheimer’s Disease 
Neuroimaging Initiative database (ADNI) (adni.loni.usc.edu). The ADNI was launched in 
2003 as a public-private partnership, led by Principal Investigator Michael W. Weiner, MD. 
The primary goal of ADNI has been to test whether serial MRI, PET, other biological markers, 
and clinical and neuropsychological assessment can be combined to measure the progression 
of MCI and early AD. Over 1,650 participants were recruited across North America during 
the first three phases of the study (ADNI1, ADNI GO and ADNI2). Around 400 participants 
were diagnosed with AD, 900 with MCI and 350 were control subjects. Three main criteria 
were used to classify the subjects (Petersen et al. 2010). The normal subjects had no memory 
complaints, while the subjects with MCI and AD both had to have complaints. CN and MCI 
subjects had a mini-mental state examination (MMSE) score between 24 and 30 (inclusive), 
and AD subjects between 20 and 26 (inclusive). The CN subjects had a clinical dementia 
rating (CDR) score of 0, the MCI subjects of 0.5 with a mandatory requirement of the memory 
box score being 0.5 or greater, and the AD subjects of 0.5 or 1. The other criteria can be found 
in (Petersen et al. 2010). 
Five diagnosis groups were considered:  
● CN: subjects who were diagnosed as CN at baseline; 
● AD: subjects who were diagnosed as AD at baseline; 
● MCI: subjects who were diagnosed as MCI, EMCI or LMCI at baseline; 
● pMCI: subjects who were diagnosed as MCI, EMCI or LMCI at baseline, were 
followed during at least 36 months and progressed to AD between their first visit and the visit 
at 36 months; 
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● sMCI: subjects who were diagnosed as MCI, EMCI or LMCI at baseline, were 
followed during at least 36 months and did not progress to AD between their first visit and 
the visit at 36 months. 
Naturally, all participants in the pMCI and sMCI groups are also in the MCI group. 
Note that the reverse is false, as some MCI subjects did not convert to AD but were not 
followed long enough to state whether they were sMCI or pMCI.  
The diffusion-weighted images (DWIs) of ADNI were downloaded in October 2016. 
They all came from ADNI GO and ADNI2 phases. Two different acquisition protocols are 
described for DWIs: Axial DTI (images with “Sequence” field starting by “AX_DTI” and 
“Axial_DTI” in the file of “IDA_MR_Metadata_Listing.csv”) and Enhanced Axial DTI 
(images with “Sequence” field equal to “Enhanced_Axial_DTI” in the file of 
“IDA_MR_Metadata_Listing.csv”). In total, Axial DTI were available for 1019 visits and 
Enhanced Axial DTI for 102 visits. Only Axial DTI images were available for the baseline 
visit (222). In the current study, we included the participants whose diffusion and T1w MRI 
scans were both available at baseline. These DWIs were acquired with the following 
parameters: 35 cm field of view, 128×128 acquired matrix, reconstructed to a 256×256 matrix; 
voxel size: 1.35×1.35×2.7mm ; scan time = 9 min; 41 diffusion-weighted directions at b-value 
= 1000 s/mm2 and 5 T2-weighted images (b-value = 0 s/mm2, referred to as b0 
image). Besides, each participant underwent a T1w MRI sequence with following parameters: 
256×256 matrix; voxel size = 1.2×1.0×1.0 mm ; TI = 400 ms; TR = 6.98 ms; TE = 2.85 ms; 
flip angle = 11°. We used quality check (QC) information provided by ADNI to select 
participants (see below Section 4.1). Moreover, QC was conducted on the results of the 
preprocessing pipeline (see below Section 4.2). Four participants were excluded because of 
the lower image resolution (4.5×4.5×4.5mm). Finally, 46 CN, 97 MCI, 54 sMCI, 24 pMCI 
and 46 AD were included.  
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Table 3 summarizes the demographics, and the MMSE and global CDR scores of the 
participants in this study. 
Table 3. Summary of participant demographics, mini-mental state examination (MMSE) and 
global clinical dementia rating (CDR) scores. Values are presented as mean ± SD [range]. M: 
male, F: female 
 
 N Age Gender MMSE CDR 
CN 46 72.7 ± 6.0 [59.8, 89.0] 
 
21 M / 25 F 28.9 ± 1.4 [24,30] 0: 46 
MCI 97 72.9 ± 7.3 [55.0, 87.8] 62 M / 35 F 27.7 ± 1.7 [24,30] 0.5: 97 
sMCI 54 72.6 ± 7.7 [55.0, 87.8] 21 M / 25 F 28.0 ± 1.7 [24,30] 0.5: 54 
pMCI 24 74.2 ± 6.1 [56.5, 85.3] 16 M / 8 F 26.8 ± 1.4 [24,30] 0.5: 24  
AD 46 74.4 ± 8.4 [55.6, 90.3] 28 M / 18 F 23.4 ± 1.9 [20,26] 0.5: 17; 1: 29;  
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4. Methods 
The classification framework is illustrated in Figure 1. It includes: tools for data management, 
image processing, feature extraction and selection, classification, and evaluation. Conversion 
tools allow an easy update of ADNI as new subjects become available. To facilitate future 
development and testing, the different components were designed in a modular-based 
architecture: processing pipelines using Nipype (Gorgolewski et al. 2011), and classification 
and evaluation tools using the scikit-learn2 library (Pedregosa et al., 2011). Thus the objective 
measurement of the impact of each component on the results could be clarified. A simple 
command line interface is provided and the code can also be used as a Python library.  
 
 
Figure 1. Overview of the framework. 
 
 
 
 
 
                                               
2 http://scikit-learn.org 
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4.1 Converting datasets to a standardized data structure 
Public datasets, such as ADNI, are extremely useful to the research community. However, 
using the ADNI can be difficult because the downloaded raw data does not possess a clear and 
uniform organization. We thus proposed to convert ADNI data into the BIDS format 
(Gorgolewski et al. 2016), a community standard which allows storing multiple neuroimaging 
modalities as well as clinical and sociodemographic data. BIDS is based on a file hierarchy 
rather than on a database management system. It can thus be easily deployed in any research 
laboratory.  
The ADNI to BIDS converter that we developed allows to automatically convert the 
raw dataset downloaded from the ADNI website to BIDS. The converter requires that the user 
has downloaded all the ADNI study data (tabular data in csv format) and the imaging data of 
interest. Importantly, the downloaded files must be kept exactly as they were downloaded. All 
conversion steps are then performed by the automatic converter, requiring no user intervention.  
Details regarding conversion of clinical, sociodemographic and T1w MRI data can be 
found in (Samper-González et al. 2018). For the DWIs, first, we selected from the file 
“IDA_MR_Metadata_Listing.csv”, all entries containing “DTI” in the “Sequence” field. 
Images with a sequence name containing “Enhanced” were discarded. Then, “IMAGEUID” 
field was matched to corresponding “loni_image” field of 
‘MAYOADIRL_MRI_IMAGEQC_12_08_15.csv’ file, to find QC information for each 
image. In cases where there existed several scans for a visit, we kept the one marked as selected 
(1 in ‘series_selected’ field of QC csv file). If there was no image marked as selected, then we 
chose the image with the best quality, (as specified in “series_quality” field, ranging from 1 to 
4, 1 being excellent and 4 being unusable), excluding the images that failed QC (series_quality 
= 4). If there were several images for the same visit and QC information was not present, we 
chose the scan that was acquired the first. Once paths for each of the selected images were 
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gathered, the images in dicom format were converted to nifti format using the dcm2niix3 tool, 
or in case of error the dcm2nii4 tool (Li et al. 2016). Images failing the conversion using both 
tools were manually discarded. Finally, the converted images in nifti format were organised in 
the corresponding BIDS folder. Note that all these steps are automatically performed by the 
converter. 
We also provide tools for subject selection according to the duration of follow up and 
the diagnose. In the present study, all the participants whose T1w MRI and diffusion MRI scans 
were available at baseline were included. Finally, we organized all the outputs of the 
experiments into a BIDS-inspired standardized structure. 
 
4.2 Preprocessing pipelines 
4.2.1 Preprocessing of T1w MRI 
The image processing pipeline for T1w MRI was previously described in (Samper-González 
et al. 2018). In brief, the Unified Segmentation procedure (Ashburner & Friston 2005) is first 
used to simultaneously perform tissue segmentation, bias correction and spatial normalization 
of the input image. Next, a group template is created using DARTEL (Ashburner 2007), from 
the subjects’ tissue probability maps in native space obtained at the previous step. Lastly, the 
DARTEL to MNI method (Ashburner 2007) is applied, providing a registration of the native 
space images into the MNI space. Besides, the GM and WM tissue maps from DARTEL 
template were binarized (with a threshold of 0.3) to obtain the corresponding tissue masks that 
are subsequently used in diffusion MRI pipeline.  
                                               
3https://github.com/rordenlab/dcm2niix 
4https://www.nitrc.org/plugins/mwiki/index.php/dcm2nii:MainPage	 
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4.2.2 Preprocessing of diffusion MRI 
For each subject, all b0 images were rigidly registered to the first b0 image and then averaged 
as the b0 reference. The raw DWIs were corrected for eddy current-induced distortions and 
subject movements by simultaneously modelling the effects of diffusion eddy currents and 
movements on the image using eddy tool (Andersson & Sotiropoulos 2016) from FMRIB 
Software Library (FSL) software (Jenkinson et al. 2012). To correct for susceptibility-induced 
distortions, as fieldmap data were not available in ADNI GO or ADNI2, the T1w MRI was 
used instead in this context. The skull-stripped b0 image was registered to the T1w MRI with 
two sequential steps: first a rigid registration using FSL flirt tool and then a non-linear 
registration using SyN registration algorithm from ANTs (Avants et al. 2008). SyN is an 
inverse-consistent registration algorithm allowing EPI induced susceptibility artifacts 
correction (Leow et al. 2007). Finally, the DWI volumes were corrected for nonuniform 
intensity using the ANTs N4 bias correction algorithm (Tustison & Avants 2013) and the 
diffusion weighting directions were appropriately updated (Leemans & Jones 2009). The 
implementation of these different steps is available in the dwi-preprocessing-using-t1 pipeline 
of Clinica. 
 We performed QC on the results of the preprocessing pipeline. Specifically, we 
inspected the results for the presence of head motion artifacts and eddy current artifacts. 
Registration quality was also visually checked by overlapping the source image onto the target 
image. All preprocessed data were considered of acceptable quality.  
The DTI model was then fitted to generate FA and MD maps using MRtrix (Tournier 
et al. 2012). FA maps were nonlinearly registered onto the JHU atlas FA template in MNI space 
with the ANTs SyN algorithm (Avants et al. 2008). The estimated nonlinear deformation was 
finally applied to the MD maps to have all the FA and MD maps in the same space. These 
procedures were implemented in the dwi-processing-dti pipeline of Clinica. 
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4.3 Feature extraction 
We extracted two types of features: voxel-wise and regional features. After image 
preprocessing, all T1w MRI and diffusion MRI are in MNI space and we have a voxel-wise 
correspondence across subjects. Voxel-wise features simply correspond to all the voxels in GM 
for T1w MRI. In order to extract the DTI-based voxel-wise features, FA and MD maps were 
masked using the tissue masks (i.e., WM, GM and GM+WM tissue binarized masks) obtained 
from T1w MRI pipeline. Then a Gaussian smoothing kernel with full width at half maximum 
(fwhm) at 8 mm was applied to the masked FA and MD maps. The resulting maps were masked 
again by the tissue masks. Thus voxels in GM, WM or GM+WM tissue maps were used as 
voxel-wise features for diffusion MRI. Regional features correspond to the average value (GM 
density for T1w MRI; FA or MD for diffusion MRI) computed in a set of ROIs obtained from 
different atlases. AAL2 atlas containing 120 ROIs (Rolls et al. 2015) was used for T1w MRI. 
Two JHU atlases, ICBM-DTI-81 white-matter labels atlas (referred as JHULabel with 48 
ROIs) and JHU white-matter tractography atlas with a 25% threshold (referred as JHUTract25 
with 20 ROIs), were used for diffusion MRI. The different features are shown in Table 4.  
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Table 4. Summary of the different types of features. 
Modality Feature Type Feature  
Diffusion MRI 
Voxel-wise 
WM-FA 
WM-MD 
GM-FA 
GM-MD 
WM+GM-FA 
WM+GM-MD 
Region-wise 
JHULabel-FA/MD 
JHUTract25-FA/MD 
T1w MRI 
Voxel-wise GM-Density 
Region-wise AAL2 
 
 
4.4 Classification 
Classification was performed using a linear SVM for both voxel-wise and regional features. 
As output of the classification, we reported the balanced accuracy, AUC, accuracy, sensitivity, 
specificity. Additionally, the optimal margin hyperplane (OMH) coefficient maps were 
reported. The OMH coefficient map represents the influence of each voxel or region on the 
classification performance. Thus, the OMH coefficient map characterizes the potential 
anatomical patterns associated to a given classifier (Cuingnet et al. 2013). 
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4.5 Cross-validation 
As emphasized in the recent literature (Varoquaux et al. 2017), it is important to properly 
perform the cross-validation (CV) procedures. In the present work, the CV procedure included 
two nested loops: an outer loop evaluating the classification performances and an inner loop 
used to optimize the hyperparameters of the model (C for SVM). More precisely, repeated 
random splits (all of them stratified) with 250 repetitions was used for outer CV. For 
hyperparameter optimization, we used an inner loop with 10-fold CV. For each split, the model 
with the highest balanced accuracy is selected, and then these selected models are averaged 
across splits to profit of model averaging.  
When FS is performed, it is crucial that FS is adequately incorporated into the CV 
procedure. FS is a process to identify relevant features and thereby reduce the dimensionality. 
It has the potential to reduce overfitting (Bermingham et al. 2015). In the present work, we aim 
to explore the impact of FS bias. The FS bias, also known as non-nested FS strategy, arises 
when FS is performed on the entire dataset and not within the CV procedure, thus introducing 
data leakage. On the contrary, a nested FS is a procedure blind to the test data and embedded 
into the nested CV (Maggipinto et al. 2017).  
Two different FS algorithms were applied: an ANOVA univariate test and an 
embedding SVM recursive feature elimination (SVM-RFE) (Guyon et al. 2002; Chandrashekar 
& Sahin 2014). Specifically, the ANOVA test can been seen as a filter without taking the 
classifier into account and was performed for each feature independently. SVM-RFE uses the 
coefficients from the SVM models to assess feature importance. Then the least important 
features, which have the least effect on classification, are iteratively pruned from the current 
set of features. The remaining features are kept for the next iteration until the desired number 
of features has been obtained. For both methods, we tested varying numbers of selected features 
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(1% of the total number of features and then from 10% to 100%, increasing by 10% at each 
step). 
 
4.6 Classification experiments 
Four different classification tasks were considered: CN vs AD, CN vs pMCI, sMCI vs pMCI 
and CN vs MCI.  
For all classification tasks, we assessed the influence of different components on the 
performance. First of all, we compared the performance obtained with different DTI metrics 
(FA, MD), different feature types (voxel, regional) and different atlases. Secondly, we 
compared the classification performance between diffusion MRI and T1w MRI. To note, the 
nested CV procedure, in each iteration, guaranteed the same subjects for data split (i.e., training 
and testing data) between modalities. Thirdly, we studied the impact of imbalanced data. Three 
tasks (i.e., CN vs pMCI, CN vs MCI and sMCI vs pMCI) have imbalanced data: the number 
of subjects of the majority group is nearly twice as many as that of the minority group. To 
assess the impact of data imbalance, a random down-sampling technique was used for each 
imbalanced task. In each iteration of the outer CV, this technique randomly excluded certain 
subjects from the majority group to ensure the subject balance between groups. Lastly, we 
evaluated the effect of FS bias. 
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5. Results 
Here, we present the results of classification tasks using original data or balanced data in Tables 
5 and 6. Balanced accuracy was used as performance metric. All the results with other 
performance metrics are available at https://gitlab.icm-institute.org/aramislab/AD-ML.  
 
Table 5. Results of all the classification experiments using original (imbalanced) data. 
Balanced accuracy was used as performance metric. Values are presented as mean ± standard 
deviation (SD).  
Imaging Modality Feature  CN vs AD 
CN vs 
pMCI 
sMCI vs 
pMCI CN vs MCI 
Diffusion MRI 
 WM-FA 0.73± 0.099 
0.52± 
0.108 
0.43± 
0.088 
0.57± 
0.090 
 WM-MD 0.71± 0.098 
0.53± 
0.087 
0.49± 
0.048 
0.59± 
0.068 
 GM-FA 0.71± 0.097 
0.59± 
0.107 
0.48± 
0.089 
0.57± 
0.088 
 GM-MD 0.76± 0.095 
0.61± 
0.115 
0.51± 
0.098 
0.60± 
0.084 
 WM+GM-FA 0.71± 0.099 
0.59± 
0.112 
0.47± 
0.094 
0.58± 
0.086 
 WM+GM-MD 0.76± 0.098 
0.60± 
0.118 
0.51± 
0.106 
0.60± 
0.088 
 JHULabel-FA 0.70± 0.107 
0.51± 
0.112 
0.47± 
0.088 
0.57± 
0.081 
 JHULabel-MD 0.50± 0 
0.50± 
0 
0.50± 
0 
0.50± 
0 
  JHUTract25-FA 0.66± 0.102 
0.54± 
0.118 
0.47± 
0.078 
0.55± 
0.077 
 JHUTract25-MD 0.47± 0 
0.50± 
0 
0.50± 
0 
0.50± 
0 
T1w MRI 
GM-Density 0.88± 0.066 
0.73± 
0.112 
0.64± 
0.113 
0.58± 
0.086 
AAL2 0.86± 0.073 
0.69± 
0.120 
0.64± 
0.118 
0.59± 
0.090 
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Table 6. Results of all the classification experiments using balanced data. Balanced accuracy 
was used as performance metric. Values are presented as mean ± standard deviation (SD). 
Imaging Modality Feature  CN vs pMCI sMCI vs pMCI CN vs MCI 
Diffusion MRI 
 WM-FA 
0.55± 
0.151 
0.44± 
0.150 
0.56± 
0.113 
 WM-MD 
0.61± 
0.140 
0.48± 
0.138 
0.55± 
0.090 
 GM-FA 
0.60± 
0.137 
0.47± 
0.151 
0.59± 
0.1073 
 GM-MD 
0.62± 
0.144 
0.51± 
0.146 
0.57± 
0.101 
 WM+GM-FA 
0.61± 
0.146 
0.44± 
0.156 
0.57± 
0.110 
 WM+GM-MD 
0.62± 
0.139 
0.51± 
0.150 
0.57± 
0.105 
 JHULabel-FA 
0.53± 
0.138 
0.47± 
0.138 
0.57± 
0.101 
 JHULabel-MD 
0.55± 
0.088 
0.48± 
0.142 
0.58± 
0.078 
  JHUTract25-FA 
0.57± 
0.135 
0.48± 
0.142 
0.54± 
0.118 
 JHUTract25-MD 
0.64± 
0.148 
0.53± 
0.144 
0.59± 
0.103 
 
 
5.1 Influence of the type of features 
Generally, voxel-wise features provided higher accuracies than regional features. While the 
difference was moderate for FA, it was particularly striking for MD: MD region-wise 
classifications did not perform better than chance for all tasks. In general, for voxel-wise 
features, the performances obtained with FA and MD were of the same order of magnitude. 
However, one can note that accuracies were (moderately but systematically) higher for MD 
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than for FA. Finally, for MD, the inclusion of GM (either in isolation or when combined with 
WM) considerably increased the performance over the use of WM alone (see Table 5). 
 
5.2 Influence of the imaging modality 
Compared to diffusion MRI, T1w MRI lead to higher accuracies for tasks CN vs AD, CN vs 
pMCI and sMCI vs pMCI (Figure 2). On the other hand, both modalities led to low performance 
for the task CN vs MCI.  
 
Figure 2. Distribution of the balanced accuracy obtained from both T1w and diffusion MRI 
for tasks CN vs AD, CN vs pMCI and sMCI vs pMCI. Both the results for voxel (top) and 
regional (bottom) feature with reference atlases are shown. 
 
 
5.3 Influence of the imbalanced data 
For voxel-wise classification, compared to the results of classification using imbalanced data, 
balanced data showed comparable accuracies for all three tasks, as shown in Figure 3. For MD 
region-wise approach, switching from imbalanced data to balanced data, accuracy considerably 
increased from 0.5 to 0.64 for task CN vs pMCI and from 0.5 to 0.59 for task CN vs MCI.  
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Figure 3. Distribution of the balanced accuracy obtained from the randomly balanced 
classifications for tasks CN vs MCI, CN vs pMCI and sMCI vs pMCI. For comparison, the 
original data classification results are also displayed. Both the results for voxel (top 2) and 
regional (bottom 2) feature are shown.  
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5.4 Influence of the feature selection bias 
To assess the influence of FS bias, the experiments were restricted to GM+WM-FA and 
GM+WM-MD features for task CN vs AD, which are the cases with the highest number of 
features and for which the performance is higher. Results are presented in Figure 4.  
For both FS algorithms, the non-nested approach resulted in vastly over-optimistic 
evaluations of performances, from 5% up to 40% increase in balanced accuracy. Specifically, 
for ANOVA, the highest balanced accuracy was obtained with the first 1% most informative 
voxels for non-nested approach (0.78 for FA and 0.83 for MD), and with all available voxels 
for nested approach (0.71 for FA and 0.76 for MD). For SVM-RFE, the highest balanced 
accuracy was achieved with the first 10% most informative voxels for non-nested approach 
(0.99 for FA and 0.83 for MD), and with the first 70% most informative voxels with FA (0.75) 
and the first 1% most informative voxels with MD (0.77) for nested approach. Compared to 
non-FS (no FS was performed), the nested ANOVA FS did not give better performance. Whilst 
while the nested SVM-RFE obtained slightly higher accuracies than non-FS: balanced accuracy 
increases from 0.71 (non-FS) to 0.75 (nested FS) for FA and 0.76 (non-FS) to 0.77 (nested FS) 
for MD.  
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Figure 4. Balanced accuracy of CN vs AD obtained varying the number of voxels for ANOVA 
and SVM-RFE approaches. (A) GM+WM-FA feature; (B) GM+WM-MD feature. 
 
 
5.5 Potential anatomical pattern  
Figure 5 displays the OMH coefficient maps for the most successful task CN vs AD. For MD 
features, discriminative voxels were mainly within the GM (hippocampus and medial temporal 
cortex) (Figure 5B). When restricting the analysis to WM, only small regions were 
discriminative and these regions where outside those of the JHUTract25 atlas (Figure 5D), 
which is consistent with the poor performances obtained with MD regional features. For GM-
density features (Figure 5C), the discriminative voxels also included these regions but were 
more extended (including some regions in the lateral temporal cortex and in the parietal and 
frontal lobes). For FA, discriminative voxels included both GM and WM regions (Figure 5A). 
In the GM, discriminative voxels were mainly located within the medial temporal lobe. In the 
WM, they were more diffuse and absent of the deep WM. These regions were close to the 
forceps minor and major tracts and inferior fronto-occipital fasciculus.  
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Figure 5. Normalized coefficient maps in MNI space. Task CN vs AD with A) GM+WM-FA 
features; B) GM+WM-MD features; C) GM-Density features; D) WM-MD features 
superimposed onto the JHUTract25 atlas (in gray). Warm colors, it means higher likelihood of 
classification into AD. 
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6. Discussion 
In the present work, we proposed an open-source framework for the reproducible evaluation of 
AD classification from diffusion MRI, which extends our previous framework devoted to T1w 
MRI and PET. We demonstrated its use to assess the influence of different components on 
classification performances, specifically i) feature types, ii) imaging modalities (T1w MRI and 
diffusion MRI), iii) data imbalance and iv) FS strategies. 
Generally, we hopefully contribute to make evaluation of machine learning approaches 
in AD more reproducible and more objective. Firstly, providing the tools to fully automatically 
convert original ADNI diffusion MRI into the community standard BIDS, we hope to facilitate 
the future work of researchers. Secondly, the literature (Uchida 2013; Cuingnet et al. 2011; Lu 
& Weng 2007) suggested that image processing procedures, including steps such as 
preprocessing, parcellation, registration and intensity normalization, have a strong influence 
on classification results. Hence, a standard diffusion MRI processing pipeline was proposed in 
the present work. Lastly, we proposed rigorous CV procedures following recent best practices 
(Varoquaux et al. 2017). The key components are publicly available in Clinica, a freely 
available software platform for clinical neuroscience research studies. We hope this framework 
will allow researchers to easily and rigorously evaluate their own classification algorithms, FS 
algorithms or image processing pipelines.  
 We then aimed to provide a baseline performance for future work. The results obtained 
in our framework were in line with the state-of-the-art. In our experiments, we obtained the 
balanced accuracy with 0.76 for task CN vs AD, 0.60 for task CN vs MCI and 0.61 for task CN 
vs pMCI. In general, the performances are low and support the idea that DTI metrics, alone, 
are not highly discriminant for AD classification. However, one can note that, in the literature, 
several studies using DTI-based features reported superior performances over our work 
(O’Dwyer et al. 2012; Nir et al. 2015; Demirhan et al. 2015; Mesrob et al. 2012; Termenon et 
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al. 2011; Graña et al. 2011). However, these discrepancies may come from i) the differences in 
image quality due to different dataset, ii) different sample size and iii) the FS bias, which we 
will specifically discuss below.  
Different types of DTI-based features were assessed. Generally, voxel-wise features 
provided higher accuracies than region-wise features. This was consistent with a previous study 
(Demirhan et al. 2015), which reported accuracies of 0.75 for region-wise classification and of 
0.88 for voxel-wise classification. Of note, the most discriminative voxels for WM-MD 
classification are outside the regions of the JHUTract25 atlas. This finding explains the poor 
performances obtained using MD regional features. Thus, the atlas used for region-wise 
approaches should be chosen with care. Moreover, FA and MD gave comparable performances 
for voxel-wise classification. This finding was supported by previous studies (Dyrba et al. 
2013; Maggipinto et al. 2017; Lella et al. 2017). One study, which adopted a non-nested FS, 
reported that MD (accuray of 0.81) outperformed FA (accuracy of 0.75) to discriminate CN 
from AD (Nir et al. 2015).  
We also systematically compared the classification performance between T1w and 
diffusion MRI. The results showed that T1w MRI outperformed diffusion MRI. Several 
previous studies have compared the performances of these two modalities. Mesrob et al found 
that T1w MRI outperformed diffusion MRI (accuracy of O.77 for T1w MRI vs 0.69 for FA 
from DTI) for task CN vs AD (Mesrob et al. 2012). However, their results were biased due to 
the adoption of a non-nested FS. Cui et al founded superior performance of T1w MRI over 
diffusion MRI (accuracy of 0.61 for T1w MRI vs 0.54 for FA from DTI) when classifying CN 
from MCI for both modalities (Cui et al. 2012). Using a predefined hippocampus ROI 
approach, Ahmed et al obtained comparable accuracies for both modalities for tasks CN vs AD 
(accuracy of O.71 for T1w MRI vs 0.72 for MD from DTI) and CN vs MCI (accuracy of O.65 
for T1w MRI vs 0.68 for MD from DTI) (Ahmed et al. 2017). Given the larger sample size and 
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proper FS procedure in our work, we believe that the superior performances of T1w MRI over 
diffusion MRI is reliable and robust. Several factors could explain the better performances of 
T1w MRI. First, it is controversial but possible that WM degeneration is a secondary 
degenerative process compared to brain atrophy (Xie et al. 2006; Agosta et al. 2011). Another 
possibility is that ADNI diffusion MRI acquisitions used within our study do not make use of 
the state-of-the-art methods that impact on image quality. In particular, no fieldmap data is 
acquired which leads to suboptimal correction of magnetic susceptibility artifacts (Wu et al. 
2008).  
We evaluated the impact of data imbalance on the classification performance. It is 
commonly agreed that imbalanced data may adversely impact the classification performance 
as the learned model will be biased towards the majority class to minimize the overall error 
rate (Estabrooks 2000; Japkowicz & Others 2000; Dubey et al. 2014). Efforts have been made 
to deal with imbalanced data, which could be generally classified as algorithmic level (Akbani 
et al. 2004) and data level (Dubey et al. 2014). In the current study, for voxel-wise 
classification, we found that the low accuracies obtained in discriminating pMCI from sMCI 
or CN are potentially caused by the small sample size, rather than by the imbalanced data. 
Interestingly, Dubey et al showed that a balanced data obtained by several data resampling 
techniques gave better results than the imbalanced data using T1w MRI from ADNI (Dubey et 
al. 2014). Thus our hypothesis for the limited sample size needs to be further confirmed as 
more subjects are becoming available.  
In the literature, researchers have emphasized that “double-dipping”, referring to the 
use of test subjects in any part of the training process, such as non-nested FS in this context, is 
bad practice and may lead to over-fitted classification (Kriegeskorte et al. 2009; Rathore et al. 
2017b). Similarly, in a recent study, Maggipinto et al showed that the adoption of FS strategies 
should be taken with care (Maggipinto et al. 2017). They proved that a biased FS, usually a 
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non-nested FS, leads to over-optimistic results. Unfortunately, many previous studies using 
diffusion MRI for AD classification adopted the non-nested FS and reported nearly perfect 
classification (O’Dwyer et al. 2012; Mesrob et al. 2012; Graña et al. 2011). In the current study, 
our finding reinforced the message that non-nested FS could result in over-optimistic results. 
With the adoption of the non-nested SVM-RFE FS, a nearly perfect performance was achieved. 
Besides, FA outperformed MD for classification accuracies for this non-nested FS approach. 
Similar patterns were also witnessed in the study of Maggipinto et al (Maggipinto et al. 2017). 
Replacing the non-nested FS with the nested one, we obtained considerably inferior 
performances. On the other hand, we found that, with SVM-RFE not with ANOVA, the nested 
FS could potentially (slightly) improve the performance compared to the case no FS was 
performed. The difference between ANOVA and SVM-RFE may stem from the fact that 
ANOVA is performed for each feature (voxel) independently while GM and WM in contiguous 
voxels are highly correlated (Mechelli et al. 2005). Interestingly, another study found that, with 
the adoption of ReliefF algorithm, FS improved the classification accuracy up to 8% compared 
to the non-FS for task CN vs AD (Demirhan et al. 2015). However, they did not give enough 
details concerning their validation scheme. In particular, it is not clear if they used a nested FS 
(Demirhan et al. 2015). 
Visualization of optimal margin hyperplane coefficient maps allowed to study which 
voxels contribute the most to the discrimination. FA, MD and GM-Density features shared a 
typical AD anatomical pattern: voxels in hippocampus and temporal lobe showed more 
discriminative ability in the classification. These findings were consistent with the literature. 
DTI-based group comparison analyses demonstrated altered FA or MD in the hippocampus 
(Fellgiebel et al. 2006; Kantarci et al. 2001; Müller et al. 2005; Müller et al. 2007; Hanyu et al. 
1998) and in the temporal lobe (Hanyu et al. 1998; Fellgiebel et al. 2005; Head et al. 2005; 
Stahl et al. 2007). Moreover, the OMH coefficient map displayed a diffuse pattern for WM 
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voxels in our work. Similar patterns of WM voxels were also witnessed in the FS procedure 
using diffusion MRI (Demirhan et al. 2015; Dyrba et al. 2013). 
Our study has the following limitations. First, ADNI diffusion MRI data was not 
acquired using the state-of-the-art methods which leads to suboptimal image quality. Related 
works have proven the negative impact of low image quality on MRI analyses (Yendiki et al. 
2014; Alexander-Bloch et al. 2016; Reuter et al. 2015). It is thus possible that diffusion MRI 
acquired using more recent protocols would provide higher classification accuracies. Second, 
our experiments were performed with a limited data sample size. The limitation came from the 
data currently available in ADNI. In a previous study (Samper-González et al. 2018), we have 
demonstrated that increased training set size led to increased classification performances. Thus, 
both limitations can result in inferior classification performances. Lastly, our study only 
explored DTI-based features. With a proper CV and FS, more sophisticated features, such as 
brain tractography- or network-based features, could also be studied.  
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